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Dietary Gluten Challenge Does Not Influence the Levels of Circulating 
Immune Complexes in Patients with Dermatitis Herpetiformis 
KIM B. YANCEY, M.D., JosEPH C. CAsoN, B.S., RussELL P. HALL, M.D., AND THOMAS J. LAWLEY, M.D. 
Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A. 
To examine the relationship between the gluten-sen-
sitive enteropathy (GSE) and lgA circulating immune 
complexes (CIC) in dermatitis herpetiformis (DH) a se-
ries of dietary gluten-challenge studies were performed 
in patients with DH and patients with ordinary GSE. 
Serial serum samples were monitored for IgA-, IgG-, and 
lgM-containing CIC levels. In the first study, 9 DH pa-
tients and 5 controls were fed 20 g of gluten flour as a 
breakfast meal on 1 of 2 consecutive study days. DH 
patients did not develop or increase their levels of CIC 
after gluten-challenge or gluten-free meals. There was 
no significant difference between the DH patients and 
the control group in regard to development of CIC. To 
evaluate the effect of dietary gluten in another form, 8 
DH patients were given meals containing 100 g of boiled 
Canadian cracked wheat. Two patients with ordinary 
GSE were also challenged with cracked wheat. Again 
there was no elevation or induction of CIC above base-
line determinations by gluten-challenge meals. These 
studies suggest that dietary gluten does not induce the 
formation of CIC in patients with DH. 
Dermatitis herpetiformis (DH) is a chronic, pruritic subepi-
dermal blistering disease characterized by the deposition of IgA 
in the dermal papillae. In addition, almost all DH patients have 
histologic evidence of a gluten-sensitive enteropathy (GSE). 
Although this enteropathy is usually asymptomatic, dietary 
gluten is fel t to play a role in the pathogenesis of the disease. 
This is supported by the restoration of small-bowel mucosal 
architectme and complete or partial clearing of skin lesions in 
the majority of DH patients maintained on strict gluten-free 
diets [1). The exact relationship between the gastrointestinal 
and cutaneous featmes of DH is not known. However, one 
theory suggests that lgA-containing immune complexes are 
formed in the bowel mucosa of DH patients, enter the circula-
tion, and later deposit in the skin, producing lesions via acti-
vation of the alternative complement pathway. 
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The recently developed IgA Raji cell radioimmunoassay [2] 
has demonstrated that approximately 25-35% of DH patients 
have lgA circulating immune complexes (CIC) [2,3). Utilizing 
this assay Zone et al recently reported that lgA-containing CIC 
were induced or significantly increased in 5 of 5 DH patients 
fed a wheat-containing meal [ 4). Induction of CIC by dietary 
challenge has been previously demonstrated in studies of IgA-
deficient patients where an increase in IgG CIC was seen after 
milk ingestion [5). 
The studies reported herein examine the influence of dietary 
challenge with gluten-free and various gluten-containing meals 
on the levels of CIC in 15 DH patients, 2 patients with ordinary 
GSE, and 5 controls as determined by the Raji cell IgA radioim-
munoassay, the Raji cell lgG radioimmunoassay, and the 1251-
Clq binding assay. The data show no significant induction or 
elevation of CIC in patients with DH or GSE after dietary 
challenge with gluten. 
MATERIALS AND METHODS 
Subjects 
Fifteen patients with DH (5 females, 10 males, age range 23-72 years) 
were studied. The diagnosis of DH was established by clinical and 
histologic features and deposits of IgA in a granulru· pattern at the 
dermal papillary tips on direct immunofluorescence. Indirect immune· 
fluorescent testing was negative for IgG, IgA, and IgM antibasement 
membrane antibodies. T en of the patients were maintained on sulfones 
alone (Diasone 165 mg daily or dapsone 25-200 mg daily). Two patients 
were being treated with sulfones and gluten-free diets and 3 patients 
were without lesions on gluten-free diets alone. All patients denied 
prior or cunent symptoms of gastrointestinal gluten intolerance.Eight 
patients had prior small-bowel biopsies; all biopsies demonstrated sub-
total villous atrophy. All DH patients were HLA-B8 positive. 
Two patients with ordinary GSE without skin lesions (1 female, 1 
male, ages 35 and 77, respectively) were also studied. The diagnosis of 
GSE was established by history, laboratory findings, and subtotal 
villous atrophy on small-bowel biopsy. Both patients were being treated 
with gluten-free diets and were asymptomatic at the start of the study. 
These patients were also HLA-B8 positive. 
Five volunteers (2 females, 3 males, age range 28-67 years) served as 
controls. The control group contained 2 HLA-B8 and 3 non-HLA-BB 
subjects. All controls were in good health. Informed consent was 
obtained from all subjects in this study. 
Dietary Challenge 
Gluten flour challenge: Nine DH patients and 5 controls were 
studied as inpatients a t the National Institutes of Health. Subjects had 
no dietary intake except water for 8 h prior to testing. Dietary challenge 
was randomized as breakfast on 1 of 2 consecutive hospital days and 
consisted of 20 g of gluten flow- (Pro Vim-Henkle Food Corporation, 
Minneapolis, Minnesota) in 8 ounces of water; this amount of gluten 
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approximated 10 slices of bread. Other meals during the 2 days of study (U;-in cpm) was developed using a panel of controls. The mean of the 
were gluten-free. A 1-day test period on glu ten res triction was per- duplicate values of each test sera (T;) is divided by U;. If this ratio (T;/ 
formed on each patient to serve as a control for a similar test period U;) is greater than 1.0, the value of the test serum exceeds the upper 
following gluten challenge. The schedule of test days was randomized 95% confidence limit and is judged abnormal. 
to avoid order effects. In this study, serum samples were obtained 
120!-Clq Binding Assay before breakfast and at 30-min intervals for 10 h on both days. 
lVhole wheat challenge: Eight DH patients were given 100 g of The 1251-Clq binding assay for the detection of CIC containing lgG or boiled Canadian cracked wheat (equivalent to 4-5 slices of bread) as a 
breakfast or midday meal. Serum samples were obtained at baseline IgM was performed as previously described [7]. The upper 95% confi-
before dietary challenge and every 30 min thereafter for 5 h. Fom dence limit of Clq binding activity in normal human sera was 10%. 
randomly selected patients on this protocol discontinued their sulfone Statistical Analysis 
therapy on request 72 h prior to testing. All 4 of these patients 
developed prw-itus and cutaneous lesions prior to dietary challenge. In the 2-day gluten-challenge study, mean values of baseline CIC 
The other 4 DH patients tested on this protocol continued maintenance determinations and means for each 30-min interval (30-570 min) on 
treatment with sulfones. gluten-free and gluten-challenge days were calculated. Comparison of 
Two patients with ordinary GSE were also fed whole wheat. They these means was then performed by the two-tailed Student's t-test. 
were first studied while on gluten-fi·ee diets with serum obtained every Data were analyzed at respective time intervals by comparing DH 
30 min for 8 h. The patients were then placed on gluten-containing patients vs. controls on gluten-fi·ee and gluten-challenge days as well as 
diets for 5-7 days until early symptoms of gluten intolerance (bloating, compru·ing DH patients vs. themselves on gluten-challenge and gluten-
loose stools, indigestion) appeared. At that time the patients were free study days. In the cracked wheat study, the two-tailed Student's 
challenged with 100 g of boiled Canadian cracked wheat and serum t-test was used to compru·e timed-sample scores with the respective 
samples were again obtained at 30-min intervals for 8 h. baseline means. 
Raji Cell Radioimmunoassays for IgA - and !gO-Containing CIC RESULTS 
Raji cell radioimmunoassays for the detection of lgA- and lgG- Dietary Challenge with Gluten Flour 
containing CIC were performed as previously described [2,6]. All serum 
In the 2-day study involving dietary challenge with 20 g of samples were tested in duplicate. Statistical analysis of data was per-
formed using a modification of the method of Woodroffe et al as gluten flour there were no significant differences between 9 DH 
previously described [2,7,8]. In brief, a daily upper 95% confidence limit patients and 5 controls in their baseline determinations of CIC. 
TABLE I. IgA-containing ClC in 9 DH patients and 5 controls after gluten flour challenge and gluten-free meals" 
Time DH Patients Normal controls 
2 3 4 5 6 7 8 9 Mean± SEM 2 3 4 5 Mean+ SEM 
Glu ten challenge: 20 g of gluten flour 
Baseline .59 .61 .96 .70 1.16 .96 .58 .62 .75 .77 ± .0693 .68 .64 .59 1.26 .83 .80 ± .1218 
30 .61 .66 .77 .90 1.20 .99 .57 .55 .72 .77 ± .0725 .73 .64 .53 1.09 .81 .76 ± .0948 
60 .62 .62 .75 .87 1.15 1.02 .64 .45 .80 .77 ± .0729 .64 .75 .52 1.12 .74 .75 ± .1005 
90 .57 .65 .77 1.00 1.21 1.31 .89 .51 .76 .85 ± .0923 .77 .64 .48 1.32 .83 .81 ± .1414 
120 .67 .64 .76 .77 1.15 .94 .74 .51 .72 .77 ± .0614 .78 .72 .62 1.34 .70 .83 ± .1296 
150 .59 .66 .81 .81 1.35 1.10 .81 .50 .79 .82 ± .0867 .73 .60 .53 1.25 .64 .75 ± .1291 
180 .61 .78 .77 1.35 1.06 .83 .52 .79 .84 ± .0921 .78 .78 .70 1.12 .76 .83 ± .0745 
210 .59 .87 .78 1.18 1.01 .64 .48 .64 .77 ± .0830 .70 .67 .69 1.11 .70 .77 ± .0842 
240 .64 .67 .73 .84 1.27 .95 .53 .64 .78 ± .0833 .68 .76 .66 .62 .64 .67 ± .0242 
270 .68 .61 .69 .87 .93 .67 .69 .73 ± .0445 .65 .53 .60 1.16 .71 .73 ± .1115 
300 .66 .67 .75 .72 1.05 .89 .58 .76 .76 ± .0523 .67 .58 .65 1.11 .84 .77 ± .0951 
330 .63 .66 .72 .70 1.06 .96 .63 .62 .81 .75 ± .0528 .71 .59 .44 1.17 .70 .72 ± .1221 
360 .65 .71 .75 .80 1.13 .92 .57 .52 .76 ± .0697 .75 .58 .66 1.30 .79 .82 ± .1264 
390 .68 .68 .79 .69 1.16 1.05 .65 .53 .91 .79 ± .0687 .63 .58 .77 1.06 .73 .75 ± .0837 
450 .78 .71 .76 .87 1.09 .99 .86 .48 .67 .80 ± .0599 .65 .68 .60 1.27 .56 .75 ± .1311 
510 .86 .65 .63 .70 1.14 .91 .56 .57 .72 .75 ± .0630 .68 .61 .56 1.31 .63 .76 ± .1393 
540 .67 .77 .71 .73 1.09 1.01 .72 .61 .75 .78 ± .0529 .68 .59 .57 1.16 .70 .74 ± .1079 
570 .65 .72 .74 1.00 .68 .67 .72 .74 ± .0450 .72 .50 .52 .58± .0702 
Gluten-free meals 
Baseline .56 .83 1.16 .76 .71 .80 ± .0994 .66 .86 .64 1.17 .79 .82 ± .0956 
30 .61 .70 .93 .85 1.22 .64 .62 .80 ± .0845 .67 .82 .57 .97 .81 .77 ± .0686 
60 .56 .63 .79 .78 1.19 .98 .56 .77 .73 .78 ± .0677 .66 .91 .56 1.39 .65 .83 ± .1507 
90 .84 .92 .74 1.35 .59 .85 .78 .87 ± .0896 .64 .78 .60 .90 .69 .72 ± .0537 
120 .61 .70 1.00 .78 1.17 1.08 .74 .76 .69 .84 ± .0653 .77 .85 .57 1.10 .78 .81 ± .0854 
150 .73 .97 .78 1.23 .73 .73 .70 .84 ± .0738 .80 .90 .60 1.21 .69 .84 ± .1054 
180 .71 .89 .77 1.14 .86 .77 .69 .77 .83 ± .0509 .78 .84 .51 1.19 .71 .81 ± .1109 
210 .71 .83 .80 1.33 .56 .72 .71 .81 ± .0928 .65 .73 .48 1.08 .95 .78 ± .1068 
240 .73 .58 .79 1.23 .89 .61 .87 .57 .78 ± .0777 .66 .97 .49 1.07 .74 .79 ± .1049 
270 .72 .68 .76 .85 1.32 .68 .63 .62 .78 ± .0811 .67 .80 .49 1.20 .61 .75 ± .1222 
300 .66 .65 .88 .76 1.23 .98 .86 .77 .72 .83 ± .0610 .62 .82 .65 1.15 .63 .77 ± .1008 
330 .60 .66 .85 .72 1.15 .97 .59 .73 .88 .79 ± .0618 .91 .62 .48 1.14 .72 .77 ± .1152 
360 .70 .65 .95 .72 1.23 .89 .60 .65 .85 .80 ± .0666 .70 .72 .45 1.28 .74 .78 ± .1361 
390 .78 .58 .86 .83 1.44 .88 .62 .58 .71 .81 ± .0880 .78 .74 .54 1.27 .71 .81 ± .1225 
450 .60 .55 .95 .80 1.25 1.04 .54 .65 .88 .81 ± .0818 .78 .75 .46 1.22 .81 .86 ± .0896 
510 .66 .66 .92 .71 1.26 .94 .73 .71 .80 .82 ± .0648 .80 .82 .74 1.03 .73 .82 ± .0543 
540 .66 .63 .99 .59 1.38 1.13 .63 .66 .84 .83 ± .0923 .75 .86 .48 1.45 .70 .85 ± .1627 
570 .63 .69 .88 .72 1.22 1.03 .71 .67 .77 .81 ± .0653 .86 .92 .47 .75 ± .1411 
" Comparison of mean determinations on DH patients and controls at baseline and time intervals 30-570 min after gluten challenge reveals no 
significant differences (p > 0.05, Students' t-test). Similru· comparisons of DH patients vs. themselves on gluten-challenge and gluten-free study 
days again show no significant differences (p > 0.05) . 
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One DH patient and 1 HLA-B8 control had elevated baseline 
determinations of 1gA-containing C1C; 3 DH patients and 1 
non-HLA-B8 control had elevated baseline 1gG-containing C1C 
levels. 1251-Clq binding exceeded 10% in 4 DH patients and 4 
controls (3 non-HLA-B8 and 1 HLA-B8) at baseline. 
The data for 1gA immune complex levels for DH patients and 
controls during this 2-day study are presented in Table I. There 
are no significant differences in lgA immune complex levels 
between DH patients and controls after the gluten-challenge 
meal. The 2-day study design of this protocol allowed DH 
patients to be compared with themselves on gluten-free and 
gluten-challenge days (Fig 1). Composite curves demonstrate 
that on 2 separate study days the 9 DH patients demonstrated 
consistent and linear patterns of 1gA immune complex levels. 
Furthermore, no significant elevations or differences in immune 
complex levels were found between the patient and control 
group using the Raji cell 1gG radioimmunoassay or the 1251-Clq 
binding assay. 
Dietary Challenge with Canadian Cracked Wheat 
In a 1-day feeding study involving 8 DH patients, 4 patients 
were tested 72 h after stopping routine maintenance therapy 
with sulfones. All 4 of these patients were symptomatic at the 
time of study with complaints of pruritus and lesion formation. 
After dietary challenge with 100 g of boiled Canadian cracked 
wheat, there was no significant increase in CIC levels above 
baseline in patients with either active or treated disease (Fig 2). 
After gluten challenge the 2 patients with ordinary GSE in 
this study failed to show an increase in IgA-, 1gG-, or IgM-
containing C1C above their respective baselines on gluten-free 
study days. All DH patients denied adverse gastrointestinal 
symptoms after dietary challenge with either gluten flour or 
boiled Canadian cracked wheat. Furthermore no objective cu-
taneous lesions developed in patients who maintained therapy 
with sulfones or strict gluten-free diets. The 2 GSE patients 
reported resolution of bowel symptoms within several days 
after resumption of gluten-free diets. 
DISCUSSION 
In the past few years the relationship between the cutaneous 
IgA deposits and the associated, usually asymptomatic GSE in 
patients with DH has received considerable attention. Gluten 
restriction usually leads to an improvement in both the small-
bowel villous atrophy and the skin lesions of DH patients [9]. 
In vitro studies of DH patients have shown increased mucosal 
IgA production which correlates with the extent of associated 
small-bowel villous atrophy [10]. Although increased mucosal 
lgA production is suspected to have some relationship with 
cutaneous 1gA deposits, the exact link between these two fea-
tures of DH has not yet been established. The generally regular 
1.0 
BASELINE 
1gA IMMUNE COMPLEX LEVELS IN 9 DH PATIENTS AFTER 
GLUTEN CHALLENGE AND GLUTEN FREE MEALS 
HOURS 
--.GLUTEN CHALLENGE 
o-- -o GLUTEN FREE 
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FIG 2. ere levels in 8 DH patients at baseline and after dietary 
challenge with 100 g of boiled Canadian cracked wheat. A, rgA Raji cell 
radioimmunoassay determinations. B, lgG Raji cell radioimmunoassay 
determinations. C, 125r-Ciq binding assay determinations. No sampling 
interval after cracked wheat challenge (30-300 min) revealed a signifi-
cant elevation of ere levels above respective baseline determinations. 
association of IgA and C3 in the skin of DH patients has led to 
speculation that mucosal immunoreactants reach the skin in 
the form of CIC. CIC have been investigated in DH patients by 
several groups using a variety of techniques [2,3,11]. IgA-con-
taining CIC have been documented in approximately 30% of 
DH patients by the Raji cell 1gA radioimmunoassay [2,3]. The 
Raji cell IgG radioimmunoassay and the 1251-Clq binding assay 
have found IgG- and 1gM-containing C1C in only 10-15% of 
these patients. No con-elation of disease activity with the pres-
ence of CIC has been identified [1]. The finding of IgA-contain-
ing CIC in such a low percentage of DH patients in these studies 
has cast doubt on the pathogenic significance of CIC in this 
disease. However, Zone et al reported a significant induction or 
increase in IgA-containing CIC after gluten-challenge meals in 
5 patients [ 4]. These authors suggested that these IgA-contain-
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ing CIC might be responsible for the cutaneous deposits of lgA 
in DH patients. They proposed that previous studies using 
random serum samples might have missed phasic elevations of 
CIC present only after periods of gluten exposure. Om studies 
in 15 DH patients and 5 controls using 2 gluten challenge 
protocols have failed to document that dietary gluten induces 
the formation of rgA-containing CIC in these patients. 
Hall et a! examined the sera of 22 GSE patients for CIC and 
found that 45% of these patients had rgA-containing CrC, while 
50% had rgG- or lgM-containing CIC [12]. Neither the presence 
nor the level of immune complexes correlated with disease -
activity in any of the patients studied. Five GSE patients were 
studied daily dw·ing sessions of dietary challenge with gluten. 
Despite the development of gastrointestinal symptoms in these 
patients, no significant change in CIC could be detected. To 
extend these observations we studied 2 GSE patients while on 
gluten-free diets and with gluten-challenge meals dming periods 
of gluten intolerance which followed 5-7 days of dietary gluten 
exposure. Blood samples obtained at 30-min intervals for 8 h 
after gluten challenge with 100 g of boiled cracked wheat failed 
to show an increase in rgA-, rgG-, or rgM-containing CIC levels 
above the baseline of gluten-free study days. 
Om findings regarding IgA-containing CIC after gluten chal-
lenge differ from those of Zone et a!. These differences may 
relate to one or a variety of study elements. Subtle differences 
may exist between the 2 groups of DH patients enrolled in 
these investigations, but this appears unlikely. Differences do 
exist in the character and quantity of gluten employed in 
challenge meals. Their challenge meal, 55 g of boiled Canadian 
wheat, was roughly equivalent to 2 slices of bread; our meals 
were approximately equal to 10 or 5 slices of bread, respectively. 
It is doubtful that inadequate gluten exposure accounted for 
our negative results. Furthermore, in the cracked wheat-chal-
lenge studies, patients were tested both on and off treatment 
with sulfones. No differences in development of CIC were 
observed in these patients. Previous studies in DH patients 
have failed to show a change in CIC levels when therapy was 
discontinued or disease flared [1]. Both studies employed the 
Raji cell radioimmunoassay for the detection of lgA- and rgG-
containing CIC; our study also included data from the 125r-Ciq 
binding assay. Although differences in Raji cell assay tech-
niques may exist between ow· groups, previous studies regarding 
the frequency oflgA-containing CIC in DH patients has yielded 
a prevalence rate of approximately 30% by both groups. The 
possibility of false negatives in ou1· assays is addressed by the 
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inclusion of positive controls in each assay and the consistent 
pattern of in1mune complex levels in patients who entered the 
study with elevated determinations. Although individual and 
group variability was noted in our studies, it was not as great as 
that observed by Zone et a!. 
In conclusion, ow· data in these studies involving 15 DH 
patients, 2 patients with ordinary GSE, and 5 controls using 2 
gluten-challenge protocols show no significant increase or in-
duction of ere after gluten-containing or gluten-free meals. 
Based on the current methods of detection used in these studies 
it is not possible to state that lgA-containing CIC form as a 
result of dietary gluten exposure. 
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